Loading clinical trials...

The Safety and Effectiveness of Taneasy and Actein in COPD Patients | Clinical Trials | Clareo Health

COMPLETEDPHASE4

The Safety and Effectiveness of Taneasy and Actein in COPD Patients

A Randomized, Safety and Efficacy Study of Taneasy 600mg Granules and Actein Effervescent Tablets 600MG in COPD Subjects

NCT06688292•Bun Yao Biotechnology Co., Ltd

View on ClinicalTrials.gov

Summary

To evaluate the safety and efficacy of Taneasy 600mg granules and Actein effervescent tablets 600MG administered twice daily for 14 days in treatment of COPD Disease.

Detailed Description

The study will enroll 40\~60 patients and complete 40 patients.

Eligibility

Age

20 - 75 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Subjects aged older than 20\~75 years old.
•2. Able to sign informed consent prior to the study.
•3. Subjects have COPD.

Exclusion Criteria

•1. Subjects with known hypersensitivity to Acetylcysteine preparations.
•2. Subjects with other serious medical diseases that are judged by the attending physician to affect the evaluation results (such as: tuberculosis, pneumonia, bronchial asthma, bronchiectasis, cor pulmonale, lung cancer, acute myocardial infarction, acute hepatitis, renal failure, etc.)
•3. Pregnancy or breast-feeding woman.
•4. Female subjects or their sexual partners do not use contraception during the trial.
•5. Joining any drug clinical trial within 3 months prior to dosing.
•6. Investigator considered to be inappropriate for enrollment.
•7. Phenylketonuria (PKU).

Locations (1)

Taichung Veterans General Hospital

Taichung, Taiwan

Key Dates

Start Date

September 20, 2024

Primary Completion Date

December 31, 2024

Completion Date

December 31, 2024

Last Updated

February 5, 2025

Enrollment

ACTUAL participants

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Interventions

Taneasy 600mg granules

DRUG

Actein effervescent 600mg

DRUG

Probiotics in Pulmonaty Rehabilitation for COPD

NCT06717659

COPD (Chronic Obstructive Pulmonary Disease)Probiotic Intervention+1 more

View study

RECRUITINGNA

Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation

NCT07072039

COPD (Chronic Obstructive Pulmonary Disease)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 5, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Safety and Effectiveness of Taneasy and Actein in COPD Patients

Inclusion Criteria

Exclusion Criteria

Probiotics in Pulmonaty Rehabilitation for COPD

Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation

Effectiveness of DITM Versus IMT in COPD Patients

Clinical Pilates Programme on People With COPD Gold A: a Rehabilitation Nursing Approach.

Investigation of the Effects of Different Exercise Approaches on Clinical Parameters in Chronic Obstructive Pulmonary Disease Patients

Comparison of Clinical Parameters in Chronic Obstructive Pulmonary Disease Patients and Healthy Individuals